High Flow Nasal Cannula Market Size, Share & Industry | 2030

Report Description

The global high flow nasal cannula market was valued at around USD 6.84 billion in 2021 and is estimated to reach USD 17.5 billion by 2030, expanding at a compound annual growth rate (CAGR) of around 11.2% during the forecast period, 2022 – 2030. The growth of the market is attributed to the increasing occurrence of respiratory-related diseases across the globe and technological advancements in high-flow nasal cannula systems.

Nasal cannulas are medical devices, used for supplying supplemental oxygen and increasing the airflow of oxygen to a patient or person suffering from respiratory diseases. Nasal cannulas are flexible and small tubes, made up of silicon tubes or lightweight plastic that comprise two open prongs that are placed inside the nostrils of the patient for oxygen supply. These tubes are attached to an oxygen cylinder and carry a steady flow of medical-grade oxygen to the nostrils.

Get Free Sample Report

High flow nasal cannula (HFNC) is an emerging cannula designed to help rapidly breathe patient who need a lot of oxygen for treating post-operative procedures or respiratory problems. It has many advantages over the low-flow nasal cannula. HFNC oxygenation therapy is utilized to deliver oxygen up to 100 humidified and heated oxygen.

High flow nasal cannula delivers around 1-3 liters of oxygen per minute and it differs as per the requirement of patients’ breathing patterns and rate. High-flow nasal cannulas can supply a mixture of air and oxygen via a humidified and heated circuit at a high flow rate.

High-flow nasal cannulas are minimally invasive than other oxygen delivery systems as they don't prohibit regular talking and eating and are easy to use and pretty portable. Such a device also reduces the risk of carbon dioxide rebreathing for the patients. High flow nasal cannula comprises a variety of products such as active humidifiers, air oxygen blenders, heated inspiratory circuits, high flow nasal cannulas, low flow nasal cannulas, consumables, and single heated. They can be utilized in several contexts, including in hospitals, clinics, ambulatory care centers, home settings, and others.

COVID-19 IMPACT on High Flow Nasal Cannula Market 

The COVID-19 pandemic has affected most of the industries operating across the globe, however, pandemic is projected to have a positive impact on the global high-flow nasal cannula market. The COVID-19 pandemic has heightened the nasal cannula market prospects with its widespread application in the treatment of various respiratory illnesses.

In fact, high-flow nasal cannula devices are anticipated to ease the complications faced by COVID-19-affected patients. High flow nasal cannula scores over conventional oxygen therapy and becomes a suitable approach to help COVID-19 patients breathe normally by providing free-flowing oxygen, as the disease primarily affects the lungs. High flow nasal cannula can regulate the temperature and moisture levels to provide greater comfort to infected patients.

Several research states that high flow nasal cannula oxygenation proves to be an effective mode of treatment for COVID-19 acute respiratory failure over non-invasive positive pressure ventilation (NIPPV). National Center for Biotechnology Information (NCBI)indicates high need for oxygen supply for patients and nasal cannula is used for the delivery of oxygen, as 39% of COVID-19 patients suffered from acute respiratory distress syndrome. The disease control and prevention centers have recommended oxygenation therapy by high-flow nasal cannula as ideal for the treatment of COVID-19.

In such a way, the pandemic encouraged the use of nasal cannula devices for providing oxygen needs which creates a lucrative opportunity for key players and boosts the nasal cannula market across the globe. For instance, Fisher & Paykel is accelerating its production of ventilators and other respiratory support and humidification products for hospitals. Furthermore, ResMed has accelerated the production of its AirCurve 10 bi-level devices to provide some comfort to COVID-19 patients.

High Flow Nasal Cannula Market Dynamics

The high-flow nasal cannula market report presents a complete overview of market dynamics by focusing on the current market trends, existing key drivers, emerging growth opportunities, and existing challenges that can shape the outcome or overall performance of the market during the forecast period, 2022 to 2030.

Major Trends:

Usage of silicone material in the manufacturing industry

The development of silicon material makes a difference in the nasal flow manufacturing industries. Surging usage of silicone material in the nasal cannula is a current trend in the high-flow nasal cannula market. Silicon-based nasal cannulas provide various advantages such as latex-free, extra soft, curved, and flared cannulas, to enhance flexibility and comfort. Increasing usage of high-flow nasal cannula therapy in treating chronic and other respiratory disease treatment has paved the way for expanding the scope and usage of the nasal cannula in patients of all ages.

Key Drivers:

Increasing incidences of respiratory-related illnesses and chronic diseases

According to the World Health Organization (WHO), respiratory illnesses such as asthma affected around 262 million people and caused the deaths of almost 461,000 people in 2019. As per the report from World Health Organization (WHO), the chronic obstructive pulmonary disease caused the third leading mortality rate worldwide with 3.23 million deaths in 2019. The increasing cases of respiratory-related illnesses and the growing rate of chronic diseases promote the high use of high-flow nasal cannulas.

The global need for surgical treatments is increasing as the geriatric population becomes more vulnerable to chronic ailments. The rising incidence and burden of chronic illnesses drive sales of air oxygen blenders and an alarming rate of trauma and accident cases around the world are all actively expanding the global high-flow nasal cannula market.

The risk associated with respiratory disorders increases, owing to the increasing instances of addiction to smoking, rising environmental pollution, and deteriorating air quality. All these factors raise demand for high-flow nasal cannula devices and equipment and are propelling the nasal cannula market growth across the globe. The growing cases of asthma in both adults and children are also driving the high flow nasal cannula market globally.

Increasing investments in R&D and growing expenditure on the healthcare system

Emerging applications of high-flow nasal cannula create tremendous opportunities for the key players operating in the global market and raise the growing demand for high-flow nasal cannula devices. A high-flow nasal cannula has been a suitable device for generating a free-flow oxygen supplement therapy for the patient, due to the outbreak of COVID-19.

The growing demand makes the major players in the global market focus more on the development of advanced cost-effective products to enhance their market position.

The manufacturing companies and other organizations are investing and funding to work on developing solution systems for respiratory disorders through research and development projects. Partnerships and collaborations with research institutions and hospitals are increasing and enabled the availability of technologically advanced products worldwide.

In fact, the development of the nasal cannula as a silicone material with extra soft, latex-free, curved, and flared cannulas enhanced the comfort and flexibility of the patients, including long-term users, this led to the growing high adoption of high-flow nasal cannula devices, and has expanded the scope and usage of the nasal cannula.

Moreover, clinical trials for evaluating new application areas and extensive research facilitated by healthcare providers to provide better integrate technologies in providing relief open up new avenues for the market. The increasing investment and healthcare expenditure under the public healthcare system in order to provide cost-effective affordable healthcare products is also driving the global high flow nasal cannula market.

Advantages over other conventional oxygen delivering systems

High flow nasal cannula oxygenation therapy has many advantages over other conventional oxygen delivery systems including conventional oxygen therapy (COT) and noninvasive ventilation (NIV), and regular nasal cannulas, generating a positive airway pressure, ameliorating oxygenation and dyspnea, by reducing the respiratory rate and work of breathing, and improve comfort. High flow nasal cannulas can provide oxygen at high flows with an optimal degree of heat and humidification.

It is well tolerated with increased flexibility for the patients such as they deliver oxygen in a variable manner that depends on the patient’s breathing rate and pattern. In acute situations patients need a higher concentration of oxygen and a non-rebreathe mask or simple oxygen mask. The advantage of nasal cannulas for patients who have  respiratory problems is that while using cannulas it is possible to talk and drink and also it reduces the risk of rebreathing carbon dioxide.

Existing Challenges:

Several risks associated with excessive use of high-flow nasal cannulas

Several risks have been linked to overuse of nasal cannula. Nasal dryness is a common complication of using nasal cannula. Nasal dryness occurs due to the streaming of cold and dry oxygen into the nostrils. Some risk to consider before utilizing any form of supplemental oxygen such as long-term use of high-flow nasal cannula has been associated with eye damage (due to the pressure build-up), lung problems, and a condition known as pulmonary oxygen toxicity, that happens when too much oxygen exists in the body and can cause damage to airways.

Complications associated with HFNC

HFNC oxygenation therapy causes airborne transmission of the virus via aerosolization. In addition, high-flow nasal cannulas are responsible for the risk of infection among health workers from virus particles spreading in the environment. Patients on HFNC are placed in private, airborne isolation rooms with full personal protective equipment (PPE) for precautionary measures to reduce such risks. These existing complications hamper high-flow nasal cannula market growth.

Emerging Opportunities:

Growing technological advancement in the healthcare system and continuous ongoing launch of advanced products

Key manufacturers are in the merge of competition towards producing effectively advanced cannulas products and their distribution to hospitals, clinics, ASCs, and home care facilities with rising demand for high-flow nasal cannulas. Major players adopt a series of business development strategies, collaborating and partnering with healthcare institutions, continuing launches, and expansion of production capacity to expand their consumer base and enhance their market share.

The growing technological advancements in the healthcare system offer lucrative opportunities for market players. For instance, ResMed’s AirSense™ 10 is the widely used series of CPAP and APAP machines, each designed to deliver high-quality therapy for a better night’s sleep.

Scope of High Flow Nasal Cannula Market Report

The report on the global high-flow nasal cannula market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

High Flow Nasal Cannula Market Segment Insights

Nasal cannula segment to account for a considerate market share

Based on product type, the global high-flow nasal cannula market is segmented into active humidifiers, air oxygen blenders, heated inspiratory circuits, nasal cannulas, consumables, and single heated tubes. The nasal cannula segment is expected to account for a considerable market share. The heated humidified high-flow nasal cannula helps people breathe rapidly, who need a lot of oxygen for treating respiratory problems or other post-operative procedures.

People living with asthma and chronic obstructive pulmonary disorder (COPD), pediatricians, newborns, and premature patients with respiratory distress syndrome employ the high-flow nasal cannula. It's also utilized in NICUs for premature babies suffering from infant respiratory distress syndrome. The increasing respiratory illnesses population at an alarming rate and the rising geriatric population raises the demand for nasal cannulas across the globe. As a result, the nasal cannula market will rise throughout the projected period, due to its emerging multiple applications in the global market.

Acute respiratory failure segment to register high market share

On the basis of application, the global high flow nasal cannula is classified as acute heart failure, acute respiratory failure, bronchiectasis, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, pneumonia, sleep apnea, cystic fibrosis asthma, airway surgery, pediatrics, cardiovascular surgery diabetes treatment, ophthalmology, gynecology, neurology, and others. The acute respiratory failure segment holds the largest market share in the global high-flow nasal cannula market and is projected to expand in the coming years.

The market growth is attributed to the increasing incidences of respiratory disorders across the globe. The changing habits of people such as smoking, growing air pollution, and deteriorating air quality are responsible for increasing cases of respiratory-related diseases at an alarming rate. The rising geriatric population who are vulnerable to respiratory illness increases the usage of nasal cannulas.

Get Free Sample Report

Hospital segment witness the large global market share

Based on the end-user, the global high-flow nasal cannula market is fragmented into hospitals, specialty clinics, ambulatory care centers, home care settings, and long-term care centers. The hospital segment accounted for a large global market revenue share of 46.5% in 2020, owing to the rising adoption of high flow nasal cannulas in hospital settings to treat severe respiratory distress.

People who are suffering from acute respiratory disorders, chronic obstructive pulmonary diseases, and acute heart failure prefer hospitals and clinics for the treatment of such diseases on a large scale The growing geriatric population and the patients with long-term respiratory distress patients routinely visit healthcare professionals in the hospitals which drives the market growth.

North America accounts for the major share

In terms of regions, the global high flow nasal cannula is divided into Asia Pacific, North America, Latin America, Europe, and The Middle East & Africa. North America segment witnessed to account for major share and is projected to expand at a rapid pace.  The market growth is attributed to the increasing use of non-invasive ventilation (NIV) & continual positive airway pressure (CPAP) equipment for patients with respiratory illnesses in home care settings.

The growing incidents of chronic obstructive pulmonary disorders, asthma, and respiratory disorders in the region are driving the market at a great length. These aforementioned reasons stimulated the growth of high-flow nasal cannulas in the market in North America. Moreover, Asia-Pacific shows impressive growth prospects for the high-flow nasal cannula market during the forecast period, owing to the increasing population, the prevalence of respiratory disease cases, the existence of key market players, and increasing expenditure on healthcare sectors.